"Lecture-casts"- A Lecture Series on General Chemistry

The STEAM Success Blueprint: An Interview with an Engineering Genius- Jee'von Pratt ( Howard University Senior Student & Graduate Student Aspirant for Georgia Tech/ NYU) ---In this episode of The STEAM Success Blueprint, we sit down with Jee'Von Pratt , an aspiring robotics engineer graduate student whose journey spans from overhauling 2-stroke marine engines in Nassau, Bahamas to pushing the boundaries of computational fluid dynamics at Howard University. Aspiring to attend graduate school at either Georgia Tech or NYU, he is on a path to making a great positive difference in the world. Also, in this interview we get the insights of this Bahamian genius, on the ideas of Dr S. Kahf and Dr. Robert Langer from UCLA and MIT respectively.---Please note the views of the podcast represent those of my guests and I, and they don't constitute medical, professional or clinical advice or suggestions. Please see a board and state certified health professional.

A Celebration of Excellence with Leaders in Academia, Medicine, Engineering, & Athletics- Black History Month Celebration! Here is the complete list: Chancellor Gary May ( Chancellor of UC Davis), Provost Raheem Beyah (Provost, Georgia Tech), Dr. Emery Brown, MD, PhD ( Anesthesiologist-Statistician, Harvard/ MIT/ Mass. General Hospital), Chase Griffin ( Toigo Fellow, Investment Fellow, Athlete Creator and Quarterback, UCLA), Nagela Nukuna (Product Lead, The White House), Dr. Shane Campbell-Staton (Evolutionary Biologist and Assistant Professor at Princeton University and Two Time Emmy Nominated PBS Host), Leselle Vincent ( Senior Associate, Center for Public Impact), Sonola Onasanya ( ESG Equity Analyst, Net Purpose), Gabriel Galaraza (Professional Services Manager, Amplitude), Kyle Woumn (Engineering Manager, Nerd Wallet and Forbes 30 Under 30, 2022), Ms. Pinder (Vice Principal, Bishop Michael Eldon School, The Bahamas), Mr. Bourne ( Chemistry Teacher, B.M.E.S.) ,Mr. R. Deveaux (Deputy Permanent Secretary, The Ministry of Education, The Bahamas), Former Ambassador S. Collie ( Former Bahamian Ambassador to Washington, DC), Mr. Isaiah Swann ( MD-PhD Student at The University of Virginia), Dr. Jenaye Burrows, MBBS (Medical Doctor), Chadwin Hanna ( MD-PhD Student, The University of Florida), Dr. Kuna Fortingo, MD ( Medical Resident), Dr. Sheena Collie (Chief Medical Officer, Doctors Hospital, The Bahamas), Aaron Levarity (Professional Basketball Player in France & from The Bahamas).

In this episode with Cray, Harvard University MD, MBA now UCLA Surgery Resident, we discuss career paths as well as mentoring and the role they play in academic and intellectual development. --The views of this podcast represent those of my guest and I. These do not constitute medical or professional advice. We disclaim any loss in any way.Music: Open sourceOriginal Recording done in August 2020.

T.S.S.B.- Interviews in Greenlandic- STEAM-ip iluatsitsinissaanut pilersaarut: Dr. Emery N. Brown ( Harvard-MIT), Dr. Robert Langer (MIT) aamma Dr. L.C. Campeau kalaallisut (kalaallisut)---The STEAM Success Blueprint: Interview Highlights with Dr. Emery N. Brown ( Harvard-MIT), Dr. Robert Langer (MIT) and Dr. L.C. Campeau in Kalaallisut (Greenlandic)--STEAM-ip iluatsitsinissaanut pilersaarut: Dr. Emery N. Brown ( Harvard-MIT), Dr. Robert Langer (MIT) aamma Dr. L.C. Campeau kalaallisut (kalaallisut)

Welcome to the STEAM Success Blueprint. We are so glad you are listening in! Today we have with us a special guest- Sonya Weigle and a special co-host- Chadwin Hanna, MD-PhD Student at the University of Florida!Sonya Weigle is a senior executive and strategic advisor in the life sciences and biotech industry, known for her expertise in leadership development, innovation strategy, and organizational transformation. Her work sits at the intersection of science, business, and leadership, helping organizations move from complexity to clarity.Throughout her career, she has partnered with executives, founders, and cross-functional teams to navigate growth, change, and high-stakes decision-making. She brings a pragmatic, human-centered approach to leadership grounded in real-world experience and informed by the evolving demands of science-driven organizations.As a speaker, Sonya is valued for her clear insights, grounded perspective, and ability to translate complex challenges into actionable strategies. Her talks resonate with leaders seeking to build resilient teams, drive innovation responsibly, and lead with confidence in rapidly evolving environments.--Please note the views of this podcast represent those of my guest and I, and do not constitute medical or professional advice, consultations or suggestions. We disclaim any loss in any way. Please see the respective professionals for specific advice or consultations.---Thanks again for listening!--Recorded in 2026

The views of this podcast represent those of my guest and I,and the translations were done using software. Any error in translation reflects that of the software, not the authors or producer.Ang mga pananaw ng podcast na ito ay kumakatawan sa mga pananaw ko at ng aking panauhin, at ang mga pagsasalin ay ginawa gamit ang software. Anumang pagkakamali sa pagsasalin ay sumasalamin sa pagkakamali ng software, hindi ng mga may-akda o prodyuser.Pandangan podcast ini mewakili pandangan saya dan tetamu saya, dan terjemahannya dilakukan menggunakan perisian. Sebarang kesilapan dalam terjemahanmencerminkan kesilapan perisian, bukan pengarang atau penerbit.

Le podcast Blueprint : Conférences Nobel en français et encréole haïtien| Podcast Blueprint la: Konferans Nobel an franse ak kreyòl Ayisyen| The Blueprint Podcast: Nobel Lectures in French &  CreoleThe views of this podcast represent those of my guest and I,and the translations were done using software. Any error in translation reflects that of the software, not the authors or producer.Les opinions exprimées dans ce podcast sont celles de moninvité et les miennes, et les traductions ont été réalisées à l'aide d'un logiciel. Toute erreur de traduction est imputable au logiciel et non aux auteurs ou au producteur.Pwen de vi ki nan podcast sa a reprezante opinyon envite mwen an ak mwen, epi tradiksyon yo te fèt ak yon lojisyèl. Nenpòt erè nan tradiksyon an reflete erè lojisyèl la, pa otè yo oswa pwodiktè a.

The Blueprint: Designing the Future of Surgery - Dr. Cray Noah, MD Returns- 2.0 (UCLA/Harvard/Georgia Tech)---Innovation isn't accidental; it's designed. Welcome to The Blueprint, a show committed to inventing the future and closing the gap between aspiration and achievement. We deconstruct the mechanics of success in modern science to provide access to the insights that matter most.On this episode with Dr. Cray and Chadwin Hanna (MD-PhD Student at University of Florida), we sit down again in December 2025, five years after his initial guest appearance with Dr. Cray Noah, a General Surgery Resident at UCLA and an emerging leader at the intersection of engineering and medicine. A graduate of Harvard Medical School and a summa cum laude Biomedical Engineer from Georgia Tech, Cray has a track record of moving technical ideas from concept to clinical practice.We dive deep into his journey, and have real conversations on wellness, success and the journey of being a surgery resident.Also, this conversation includes:The Future of Transplants: His current feasibility study using hematopoietic stem cells to eliminate long-term immunosuppression in liver transplant recipients.From the GT environment to the operating room, this is a masterclass in navigating—and leading—the next era of discovery.Definitely an episode worth listening to. Please note: The views of this podcast represent those of my guest and I, and do not constitute medical advice, suggestions, or opinions. We disclaim any loss in any way.Music is open source.

Bridging the Gap Beyond the Textbook: Integrating Flash Cards and Audio for Organic Chemistry---We are bridging the gap between visual and auditory learning in organic chemistry. By integrating 500 reactions from open-source reaction cards from Educational Reaxy’s Flash App with deep-dive podcast audio, we have created an immersive, multi-sensory tool for mastering named reactions. This project is designed to make complex chemistry concepts more accessible and engaging.Note: This content is for educational purposes only.

Oye 4 DC City Council- The Blueprint: Evidence Over "Rearrangements and Vibes" — No “SN1 Chemistry-like Policies” with Dr. Oye Owolewa, PharmD- Oye 4 DC City Council--Blueprint: Evidence Over "Rearrangements and Vibes" — No “SN1 Rearrangement-like Policies”Guest: Dr. Oye Owolewa, PharmDGuest BioUnited Sates Representative Oye Owolewa (D-D.C.) is a dedicated public servant and community advocate committed to uplifting the voices of underserved communities. Elected in 2020 as the U.S. Representative for the District of Columbia, Rep. Owolewa made history as the first Nigerian American elected to Congress. His leadership is rooted in a passion for equity, social justice, and empowering marginalized populations.Born to Nigerian immigrant parents, Rep. Owolewa grew up in Massachusetts before moving to Washington, D.C., where he earned his Doctorate in Pharmacy from Northeastern University. His background in healthcare has fueled his advocacy for accessible and affordable healthcare, mental health resources, and economic empowerment.Prior to his role in Congress, Rep. Owolewa actively served his community through various grassroots initiatives. He worked closely with local organizations to provide educational support, mentorship, and resources for D.C. residents. His focus on youth engagement and civic education has inspired young leaders to become active participants in their communities.In Congress, Rep. Owolewa continues to champion policies that promote racial and economic equity, expand mental health support, and address systemic injustices. He is a strong advocate for D.C. statehood, ensuring that residents of the nation's capital have full representation in Congress. His legislative priorities include economic development, healthcare awareness, and youth empowerment, aiming to create opportunities and resources for all D.C. residents.With a steadfast commitment to service, Rep. Owolewa remains dedicated to improving the lives of his constituents and building a more inclusive and just society for all.Episode SummaryWhat happens when you apply mechanistic thinking—Woodward-level rigor and Percy Julian-level ingenuity—to public policy in Washington, D.C.? In this episode of Blueprint: Inventing the Future, we speak with Dr. Oye Owolewa, PharmD, who is running for DC City Council, exploring how clinical precision and evidence-based reasoning can translate into durable solutions for STEAM education, workforce development, digital equity, mental health, and civic empowerment.We frame D.C. governance like an organic synthesis problem: stabilize intermediates, control reaction conditions, eliminate “side reactions,” and design for yield—so opportunity is not theoretical, but repeatable.Music Credit: Music: Reach The Top by Shane Ivers - https://www.silvermansound.com```

In this re-aired interview we produce a conversation that is both informative and enjoyable to listen to, with a mentor and newly appointed Provost at Georgia Tech, Dr. Raheem Beyah!--Please note the views of this podcast represent those of my guest and I. Music credit: Open source

Vision, Impact, and Knowledge- An Interview with Dr. Robert Langer, an Educational Debate on Cancer , and a Review of Cancer Biology---Disclaimer:The views of this podcast reflect those of my guests and I, and do not constitute medical or professional advice or consultation. Please see a state certified and board certified health professional for medical and professional advice. Again, we disclaim any loss in any way, and this podcast does not in any way represent a company endorsement and medical recommendation.--Translation done using the assistance of software, any errors in translation reflect the software, and not that of the guest or host.---Article Reference:⁠Understanding the Relationship Between Germ Layer Origin and Cancer Therapy Response: An Analysis and Synthesis⁠

The Current: Discovering Chemistry's Zeitgeist- Flashback to Graduate School and the Central Dogma- Visual Lecture---Please note the views of this podcast represent those of my guest and I, and AI may have been used in the production of the episode. Please see a board-certified medical professional, that is state licensed for medical or professional advice. We disclaim any loss in any way.

"From BMES to the States: Excellence, Athletics, and Building Bridges Across Cultures"- A Conversation with Antonio Smith, A Longstanding Highschool Friend and Quality Control Leader---Episode Description:Join me for a cool conversation with one of my closest friends, Antonio Smith, as we dive deep into a journey that spans two countries, multiple sports, and the pursuit of excellence that started at Bishop Michael Eldon School in FreeportAntonio made the bold decision to leave one of the Bahamas' top schools in his senior year to pursue opportunities in Tallahassee, Florida. From competing in three sports at James S. Richards High School to building a successful career as a Quality Control Team Lead at KUS, his story embodies the resilience and work ethic that elite Bahamian education instills.We explore the cultural bridges between the Bahamas and the United States, the challenges of maintaining community connections while building a new life abroad, and the entrepreneurial spirit that led him to co-found a shopping and shipping company serving the Bahamian diaspora. This conversation touches on athletics, education, career development, cultural identity, and the ongoing connection to home that shapes the immigrant experience.Whether you're interested in Caribbean education systems, the student-athlete experience, quality control leadership, or the dynamics of diaspora communities, this episode offers authentic insights from someone who has successfully navigated multiple worlds while maintaining his roots.Topics Covered:Elite Bahamian education and its impact on character developmentStudent-athlete transitions between Caribbean and American systemsCareer progression from physical education studies to quality control leadershipEntrepreneurship within diaspora communitiesMaintaining cultural identity while adapting to new environmentsThe realities of building a life between two countriesDisclaimer:The views and experiences shared in this episode are those of the guest and host based on their personal journeys. While we discuss educational institutions, athletic programs, and cultural comparisons, these perspectives reflect individual experiences and should not be considered representative of all students, athletes, or community members from these backgrounds. Career and life decisions discussed are personal choices that may not be suitable for everyone. Listeners considering similar educational or geographic transitions should conduct their own research and seek appropriate guidance for their specific circumstances.The views expressed do not constitute medical or professional advice. Please see a board certified and state licensed health professional for medical and professional advice. We disclaim any loss in any way.Music citation: Music by ⁠Andrii Poradovskyi⁠ from ⁠Pixabay

The Riemann Key: Unlocking Modern Nobel Discoveries of the Past with a 19th-Century Thesis--Please note the views of this podcast represent those of my guest and I, and AI may have been used in the production of the episode. Please see a board-certified medical professional, that is state licensed for medical or professional advice. We disclaim any loss in any way.

From Lab Bench to Bedside: Cardiolipin Science Saves Lives- The Significant Connection between D.J. Ferguson's Master's Thesis and Forzinity's Recent Approval----On September 19, 2025, the FDA granted accelerated approval to FORZINITY™ (elamipretide), a groundbreaking new drug for Barth syndrome—an ultra-rare genetic disorder affecting only about 150 people in the United States. On the surface, it's a monumental victory for a small but desperate community. But what if this victory is also a critical clue, a key that could unlock a new frontier in the fight against some of the world's most widespread neurological diseases?This approval marks the first-ever therapy specifically targeting mitochondria, the powerhouses of our cells. The implications are staggering, potentially paving the way for new approaches to treating conditions like Alzheimer's and Parkinson's, where mitochondrial dysfunction is a known culprit.Join us as we unravel this historic first, exploring the intricate science and the decade-long journey of perseverance that led to this moment.In this episode, we explore:The World of Barth Syndrome: We define this devastating and ultra-rare genetic disease, understanding its profound impact on patients and the cellular machinery it disrupts.The Unsung Hero of Our Cells: A deep dive into the science of mitochondria and a crucial molecule you’ve likely never heard of—cardiolipin. Learn why this unique phospholipid is the linchpin of cellular energy and structural integrity.A Targeted Therapy: Discover how FORZINITY™ (elamipretide) works by directly interacting with and stabilizing cardiolipin, restoring function at the very source of the problem.The Road to Approval: We chart the high-stakes, dramatic journey of Stealth BioTherapeutics, from a major FDA rejection to a strategic pivot that secured a historic accelerated approval.The Broader Horizon: We connect the dots from Barth syndrome to neurodegeneration, exploring the mounting evidence that links cardiolipin dysfunction to the pathology of Alzheimer's and Parkinson's disease, and what this breakthrough means for the future of medicine.Disclaimer:The views of this podcast reflect those of my guests and I, and do not constitute medical or professional advice or consultation. Please see a state certified and board certified health professional for medical and professional advice. Again, we disclaim any loss in any way, and this podcast does not in any way represent a company endorsement and medical recommendation.⁠Link: Understanding Cardiolipin's Function in Neurodegenerative Diseases- A Flashback | Research Communities by Springer Nature⁠

A Celebration of Excellence with Leaders of Color in Academia, Medicine, Engineering and Athletics. Here is the complete list: Chancellor Gary May ( Chancellor of UC Davis), Dean Raheem Beyah (Dean, College of Engineering, Georgia Tech), Dr. Emery Brown, MD, PhD ( Anesthesiologist-Statistician, Harvard/ MIT/ Mass. General Hospital), Chase Griffin ( Toigo Fellow, Investment Fellow, Athlete Creator and Quarterback, UCLA), Nagela Nukuna (Product Lead, The White House), Dr. Shane Campbell-Staton (Evolutionary Biologist and Assistant Professor at Princeton University and Two Time Emmy Nominated PBS Host), Leselle Vincent ( Senior Associate, Center for Public Impact), Sonola Onasanya ( ESG Equity Analyst, Net Purpose), Gabriel Galaraza (Professional Services Manager, Amplitude), Kyle Woumn (Engineering Manager, Nerd Wallet and Forbes 30 Under 30, 2022), Ms. Pinder (Vice Principal, Bishop Michael Eldon School, The Bahamas), Mr. Bourne ( Chemistry Teacher, B.M.E.S.) ,Mr. R. Deveaux (Deputy Permanent Secretary, The Ministry of Education, The Bahamas), Former Ambassador S. Collie ( Former Bahamian Ambassador to Washington, DC), Mr. Isaiah Swann ( MD-PhD Student at The University of Virginia), Dr. Jenaye Burrows, MBBS (Medical Doctor), Chadwin Hanna ( MD-PhD Student, The University of Florida), Dr. Kuna Fortingo, MD ( Medical Resident), Dr. Sheena Collie (Chief Medical Officer, Doctors Hospital, The Bahamas), Aaron Levarity (Professional Basketball Player in France & from The Bahamas).

The Path to KOLs--Ukranian Episode: Шлях до KOL: Наука, Лідерство та Сила Малих Кроків (The Path to KOL: Science, Leadership, and the Power of Small Steps)--До кожного, хто переживає складний період: пам’ятайте, що тіні є доказом існування світла. Коли шлях уперед незрозумілий, а тягар світу здається надто важким, тримайтеся за тиху силу, яка живе всередині вас.Як нагадував доктор Мартін Лютер Кінг, молодший: «Віра — це зробити перший крок, навіть коли ви не бачите всієї сходової клітки». Ваша подорож не полягає в тому, щоб бачити кінець від самого початку, а в тому, щоб мужньо зробити наступний крок. У хвилини випробувань ми часто знаходимо найбільші можливості.Ласкаво просимо до “Шляху до KOL” — студентського подкасту, що надихає студентів клінічної фармації, майбутніх резидентів та молодих клініцистів. У кожному епізоді беруть участь світові лідери думок — канцлер Ґері Мей; доктор Роберт Ленґер; Ґреґ Цукерман (The Wall Street Journal); Кайл Вумн (Forbes 30 Under 30) — які діляться своїми поглядами на проривні дослідження, лідерство, інновації та кар’єри у фармації, орієнтовані на цінності й мету.Нехай виклики, з якими ви стикаєтесь, зміцнюють вашу рішучість. Як писав святий Августин: «У надії є дві прекрасні дочки: їхні імена — Гнів і Відвага. Гнів на те, що є, і Відвага, щоб зробити так, аби все не залишалось таким самим». Використовуйте цю відвагу не в одному великому жесті, а в малих, послідовних діях, які ви робите щодня. Мати Тереза навчала простої, але глибокої істини: «Ми не можемо робити великих справ, лише маленькі справи з великою любов’ю».Відмова від відповідальності: цей контент не є медичною порадою чи рекомендаціями. Звертайтеся за порадами до сертифікованих медичних фахівців на рівні ради, штату чи місцевих органів. Ми відмовляємося від будь-якої відповідальності за будь-які втрати.----English:To anyone navigating a difficult season, remember that the shadows are proof of the light. When the path ahead is unclear and the weight of the world feels heavy, hold on to the quiet strength that resides within you.As Dr. Martin Luther King, Jr. reminded us, "Faith is taking the first step even when you don't see the whole staircase." Your journey is not about seeing the end from the beginning, but about bravely taking that next step. In moments of trial, we often find our greatest opportunities. Welcome to The Path to KOL, the student-led podcast empowering clinical pharmacy students, residency aspirants & rising clinicians. Each episode features global thought leaders—Chancellor Gary May; Dr Robert Langer; Greg Zuckerman (The Wall Street Journal); Kyle Woumn (Forbes 30 Under 30)—sharing insights on breakthrough research, leadership, innovation & purpose-driven pharmacy careers.Let the challenges you face fuel your resolve. As St. Augustine wrote, "Hope has two beautiful daughters; their names are Anger and Courage. Anger at the way things are, and Courage to see that they do not remain as they are." Use that courage not in one grand gesture, but in the small, consistent actions you take every single day. Mother Teresa taught a simple yet profound truth: "We can do no great things, only small things with great love."Disclaimer: This content is not medical advice or suggestions. Consult board-, state-, and locally certified health professionals for medical advice. We disclaim any liability for any loss.

On The Path to KOLs from The New Chemist’s Podcasting Group, hosts David Ferguson and Chadwin Hanna explore how Latin America is becoming a strategic engine for high-quality, cost-effective clinical research.Julio G. Martinez-Clark—Ambassador of IAOCR/GCSA Americas and CEO of bioaccess®—breaks down how aligning to global competence standards and smarter site activation can compress timelines for First-in-Human and Early Feasibility Studies without compromising quality. He shares lessons from pioneering trials, practical blueprints for building city-level clinical hubs, and pragmatic guidance for innovators entering LATAM markets. The conversation also touches on sustaining regional infrastructure, cross-border collaboration, and the mindset behind his long-running Global Trial Accelerators™ series.Guest: Julio G. Martinez-Clark, CEO, bioaccess®Hosts: David Ferguson, BS, MS, Pharm.D. Candidate; Chadwin Hanna, MD Candidate & PhD StudentPlease note: The views of this podcast reflect those of my guest(s) and I, and do not constitute medical advice, consultation and suggestions. Please see a board certified and state licensed medical professional.

In this interview we discuss with a leading pioneer in chemistry, Dr. L.C. Campeau, his career and his accomplishments thus far, and what has been an impetus for his achievements. Dr. L.C. Campeau is also a Fellow of the Royal Society of Canada.--Dr. Campeau's Biography:L.-C. Campeau obtained his Ph. D. degree in 2007 with the late Professor Keith Fagnou at the University of Ottawa in Canada as an NSERC Doctoral Fellow, after completing his B.Sc. in Biopharmaceutical Sciences. He was the recipient of the Pierre Laberge Prize for the best Ph.D. thesis in the Science Faculty. The Faculty of Science awarded him the inaugural Young Alumni Award in 2016 and in 2022 he received the inaugural Department of Chemistry and Biomolecular Sciences Distinguished Alumni Award. L.-C. first joined Merck Research Laboratories at Merck-Frosst in Montreal in 2007 making key contributions to the discovery of Doravirine (MK-1439) for which he received a Merck Special Achievement Award. In 2010, he moved from Quebec to New Jersey, where he has served in roles of increasing responsibility Head of Catalysis & Automation, Head of Discovery Process Chemistry and Head of Process Chemistry. L.-C. is currently Associate Vice President and the Head of Small Molecule Process Research and Development, leading a team of smart creative scientists and engineers developing innovative solutions in support of all discovery, pre-clinical and clinical active pharmaceutical ingredient deliveries for the entire Merck portfolio for small-molecule therapeutics. Over his tenure at Merck, L.-C. and his team have made important contributions to >40 clinical candidates and 7 commercial products to date. Under his leadership, his organization has received the EPA’s Green Chemistry Challenge Award four consecutive years and received the Heroes of Chemistry Award for their work on Molnupiravir in 2022. His passion for scientific excellence exemplified by >80 publications and patents, several successful collaborations with key academics, and an extensive list of >85 invited lectures worldwide. As a proud Canadian, L.-C. continues his engagement in the Canadian chemistry community, serving 4 years on the NSERC Discovery Grants committee (2019-2022) and currently sits on the NSERC National Awards Selection Committee. L.-C. was elected Fellow of the Royal Society of Canada in 2022.

Remixed- The Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai---In this episode we provide and educational episode remix made with software assistance ( for educational purposes only) , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to explore how AI-driven single-cell analytics are revolutionizing precision oncology. Discover how the OncoIncytes platform merges ctDNA, live CTCs, single-cell RNA and proteomics for a real-time, multimodal tumor profile—and learn how these insights are sharpening patient selection, accelerating ADC trials, and delivering earlier, more accurate measures of therapeutic response. Mohan also shares his playbook for building a capital-efficient biotech across Silicon Valley and India, the emerging trends set to reshape drug development, and practical advice for chemists, data scientists, and founders looking to break into the field. Tune in this August for a deep dive into the future of cancer research and drug discovery.--Please note: The views of this podcast represent those of my guest(s) and I, and do not constitute professional or medical advice or consultation. Please see a medical professional or healthcare professional for advice, suggestions and consultations. We disclaim any loss in any way.Music citation: Open source

Highlighted Episode- The Path to KOLs: Nobel Lecture Compendium (100+) with AI-Powered OverviewsIn this episode, we compile over 100+ Nobel Lectures and key lectures and use AI LLMs to produce video overviews of those lectures.Please note: The views of this podcast represent those ofmy guest and I, and do not constitute medical, professional or financial advice or consultation. Please refer to the state and board-certified professionals. We disclaim any loss in any way.

 Episode DescriptionIn this episode, we sit down with Sam Libby,President and Managing Director at TCB Capital Advisors, whose career has been dedicated to transforming healthcare through strategic investments and partnerships. With more than 30 completed transactions —spanning mergers and acquisitions, capital raises, and innovativedeal structures—Sam has become a trusted advisor at the intersection of finance, science, and patient care.Our conversation dives deep into his origin story—fromRutgers to leading one of the most dynamic advisory firms in healthcare—and explores how his investment philosophy balances patient-centered missions with the financial discipline demanded by markets. Sam shares case studiesfrom groundbreaking ventures like Clairity, the first FDA-cleared AI breast cancer risk platform, and Altoida, a pioneer in early cognitive assessment technology, offering valuable lessons for founders and investors alike.We also discuss the critical role of strategicpartnerships, the evolving dynamics between founders and investors, and the exciting frontiers shaping the future of healthcare—from oncology and neurodegeneration to women’s health and digital innovation. Sam highlights how AI and data are reshaping deal-making, due diligence, and commercialization pathways. Finally, Sam offers practical advice for aspiring thought leaders and entrepreneurs on refining their pitch, stepping into leadership beyond the lab, and positioning themselves for long-term impact in arapidly evolving industry.Whether you’re a scientist, entrepreneur, investor, orfuture healthcare leader, this episode provides insightful perspectives on the business of innovation, the art of deal-making, and the mission to improve patient outcomes.Music citation: open-source classical musicPlease note: The views of this podcast represent those ofmy guest and I, and do not constitute medical, professional or financial advice or consultation. Please refer to the state and board-certified professionals. We disclaim any loss in any way. 

🎙️ Episode DescriptionIn this episode, we sit down with Sam Libby,President and Managing Director at TCB Capital Advisors, whose career has been dedicated to transforming healthcare through strategic investments andpartnerships. With more than 30 completed transactions —spanning mergers and acquisitions, capital raises, and innovative deal structures—Sam has become a trusted advisor at the intersection of finance, science, and patient care. Our conversation dives deep into his origin story—from Rutgers to leading one of the most dynamic advisory firms in healthcare—and explores how his investment philosophy balances patient-centered missions withthe financial discipline demanded by markets. Sam shares case studies from groundbreaking ventures like Clairity, the first FDA-cleared AI breast cancer risk platform, and Altoida, a pioneer in early cognitive assessment technology, offering valuable lessons for founders and investors alike.We also discuss the critical role of strategicpartnerships, the evolving dynamics between founders and investors, and the exciting frontiers shaping the future of healthcare—from oncology and neurodegeneration to women’s health and digital innovation. Sam highlights how AI and data are reshaping deal-making, due diligence, and commercialization pathways. Finally, Sam offers practical advice for aspiring thought leaders and entrepreneurs on refining their pitch, stepping into leadership beyond the lab, and positioning themselves for long-term impact in arapidly evolving industry.Whether you’re a scientist, entrepreneur, investor, orfuture healthcare leader, this episode provides insightful perspectives on the business of innovation, the art of deal-making, and the mission to improve patient outcomes. 

In this highlighted, re-aired, fireside chat, remixed episode, and podcast interview with Simar- a Marshall Scholar and graduate of Harvard University, we discuss Simar's achievements in science communication, his perseverance, and the hard work required to produce good work, science communication, and good journalism. Furthermore, Simar provides insights as he is a developing and achieving young leader in the science and journalism arenas. Definitely an episode worth listening to!Here are the links to his website and LinkedIn Page:1. Simar's website: https://www.simarbajaj.com/2. Simar's LinkedIn: https://www.linkedin.com/in/simar-bajaj/----Note: The views of this podcast represent those of my guest(s) and I.Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational andintellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice andsuggestions.---Recorded in 2023

In this highlighted episode of The New Chemist’s Podcasting Group’s — The Path to KOLs, host David Ferguson sits down with Christine Hollis, Chief Talent & Diversity Officer at Marshall Gerstein. Christine has dedicated her career to guiding scientists and engineers into impactful roles within intellectual property law, bridging the worlds of innovation and legal protection.She shares insights on:Pathways for STEM talent to enter IP law as patent agents or technical specialists.The skills scientists bring to legal environments and innovation ecosystems.Strategies for diversity, equity, and inclusion in science-driven law.The future of STEM-law collaboration in an era of AI, biotech, and medtech.Whether you’re a student, scientist, or innovator, Christine’s vision will broaden your perspective on how STEM expertise can shape industries beyond the lab.Disclaimer: These episodes do not constitute medical or professional advice. These are only for intellectual engagement. Please see your local and board-certified health professional for medical advice, consultation, and suggestions.Music by Viacheslav Starostin from Pixabay

Highlights from: The New Chemist’s Podcasting Group — The Path to KOLs: Accelerating First-in-Human in LATAM — Julio G. Martinez-Clark, CEO, bioaccess® w/ Chadwin Hanna, MD-PhD Student (UF) and David Ferguson (Host)In this episode, on The Path to KOLs from The New Chemist’s Podcasting Group, hosts David Ferguson and Chadwin Hanna explore how Latin America is becoming a strategic engine for high-quality, cost-effective clinical research.Julio G. Martinez-Clark—Ambassador of IAOCR/GCSA Americas and CEO of bioaccess®—breaks down how aligning to global competence standards and smarter site activation can compress timelines for First-in-Human and Early Feasibility Studies without compromising quality. He shares lessons from pioneering trials, practical blueprints for building city-level clinical hubs, and pragmatic guidance for innovators entering LATAM markets. The conversation also touches on sustaining regional infrastructure, cross-border collaboration, and the mindset behind his long-running Global Trial Accelerators™ series.Guest: Julio G. Martinez-Clark, CEO, bioaccess®Hosts: David Ferguson, BS, MS, Pharm.D. Candidate; Chadwin Hanna, MD Candidate & PhD StudentPlease note: The views of this podcast reflect those of my guest(s) and I, and do not constitute medical advice, consultation and suggestions. Please see a board certified and state licensed medical professional.

Highlights from: The New Chemist’s Podcasting Group: The Path to KOLs — Interview with Dr. Michael A. Morris, MD, MS, DABR, DABNM, DCI — Co-Founder, United Theranostics---🎙️ In this episode of The Path to KOLs, Dr. Michael A. Morris, MD, MS, DABR, DABNM, DCI—co-founder of United Theranostics—explains how his team is moving Pluvicto from single mega-centers into safe, consistent community clinics. We dig into the toughest regulatory and logistical hurdles, the playbook for dosing accuracy, imaging quality, and safety, and how clinics are designed for a compassionate, family-centered patient journey with real-world feedback loops.Dr. Morris also shares how United Theranostics trains local technologists, pharmacists, and nurses, mentors future KOLs, and maps a path to coverage across all 50 states. Looking ahead, we discuss what’s beyond Pluvicto—including actinium-225 PSMA approaches—and how telehealth, remote monitoring, and AI are improving patient selection, follow-up, and outcomes.About the guest: Dr. Morris is a physician-scientist in nuclear medicine, diagnostic radiology, and clinical informatics; Medical Director in Glen Burnie, MD; adjunct faculty at the University of Miami and University of Maryland; and a principal investigator on multiple FDA clinical trials in prostate cancer and neuroendocrine tumors.Subscribe for actionable insights at the intersection of innovation, operations, and patient-centered care.Music by Dmitrii Kolesnikov from PixabayPlease note: The views of this podcast reflect those of my guest(s) and I, and do not constitute in any way medical advice or consultation. Please see a board and state certified medical professional for advice, consultation and suggestions.

Highlights from: The Making of KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai---In this episode , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to explore how AI-driven single-cell analytics are revolutionizing precision oncology. Discover how the OncoIncytes platform merges ctDNA, live CTCs, single-cell RNA and proteomics for a real-time, multimodal tumor profile—and learn how these insights are sharpening patient selection, accelerating ADC trials, and delivering earlier, more accurate measures of therapeutic response. Mohan also shares his playbook for building a capital-efficient biotech across Silicon Valley and India, the emerging trends set to reshape drug development, and practical advice for chemists, data scientists, and founders looking to break into the field. Tune in this August for a deep dive into the future of cancer research and drug discovery.--Please note: The views of this podcast represent those of my guest(s) and I.Music citation: Open source

In this highlighted re-aired episode, Abhinaya discusses her academic successes thus far and her advice to those wanting to pursue Medical Device/ Engineering job field.-- Music citation: ⁠Ievgen Poltavskyi⁠⁠ from ⁠⁠Pixabay⁠⁠Please note: The views of this podcast represent those of my guest(s) and I.Interview recorded in 2021.(c) The New Chemist Podcasting Group

This curated compilation with leaders such as Dr. Etienne, and Dr. Langer, as well as early career professionals and students such as MD-PhD Student Chadwin Hanna, Dr. Ugo, Dr. Maada, and PharmD Student David Ferguson, stitches together the most resonant moments from four interviews recorded in 2020, 2023, 2024, and 2025 with Institute Professor Robert Langer, Sc.D. . Across a half-decade marked by pandemic breakthroughs, startup surges, and classroom innovation, Dr. Langer reveals how impact-driven work fuels transformative work at the intersection of bioengineering, academia, and industry.

In this special episode of The New Chemist's Podcast, we explore the brilliance of Nobel Prize lectures in science, presented in both English and Hebrew. Join us as we highlight groundbreaking discoveries and honor the scientists who have shaped our understanding of the world—from Stockholm to the global stage.Please note the views of this podcast reflect those of my guest(s) and I. Also, these views do not constitute medical or professional advice. Please see the relevant board-certified and state licensed professionals.--בפרק מיוחד זה של הפודקאסט של הכימאי החדש, אנו בוחנים את הזוהר של הרצאות פרס נובל במדע, המוצגות באנגלית ובעברית. הצטרפו אלינו כשאנו מדגישים תגליות פורצות דרך ומכבדים את המדענים שעיצבו את הבנתנו את העולם - משטוקהולם ועד לבמה העולמית.שימו לב שהדעות של הפודקאסט הזה משקפות את אלה של האורחים שלי ושלי. כמו כן, דעות אלה אינן מהוות ייעוץ רפואי או מקצועי. אנא פנה לאנשי המקצוע הרלוונטיים המוסמכים והמורשים על ידי המדינה.

In this special bilingual episode, we explore the 2024 Nobel Prizes in Chemistry, Medicine, and Economics. From groundbreaking mRNA research to advancements in quantum dots and behavioral economics, we unpack the science—and the stories—behind the world's most prestigious awards.本期特别节目，我们以中英双语带大家了解2024年诺贝尔奖中的三大重点领域：化学奖、医学奖与经济学奖。节目将介绍mRNA技术的医学突破、量子点的化学奇迹，以及行为经济学的新发展，一起探索这些改变世界的研究成果！Tune in to:Learn what each prize was awarded forHear insights from both scientific and global perspectivesPractice your Chinese and English listening skills in a natural, engaging context欢迎科学爱好者、语言学习者以及对诺贝尔奖好奇的你一同收听！🎧 Available now on all major platforms.🎙️ 请在各大平台搜索收听！--Some of the content produced involved the use of AI.

Highlights from: The New Chemist's Podcast: From Stockholm to the World: Nobel Lectures in the Sciences in English, 中文 (Chinese), and Deutsch (German)--Please note these views do not reflect or constitute medical or professional advice or consultations. Please see the relevant board and state certified professionals. We disclaim any loss in any way.--Note some of the production of this episode, involved the use of AI.

In this episode of The New Chemist’s Podcast, we’re thrilled to welcome the iconic Jason Mraz, a Grammy Award-winning singer-songwriter, known for timeless hits like "I’m Yours" and "Lucky". 🎶But Jason is more than just a musician—he is a passionate environmental advocate, using his platform to raise awareness about sustainability, regenerative agriculture, and soil health. 🌱 Joining him is Mr. Makespeace, an environmentalist dedicated to fostering change and protecting the planet. Together, they discuss their journeys in music and environmental activism, especially through their involvement in the Kiss the Ground movement.🎙️ Join David Ferguson as he, Jason, and Mr. Makespeace explore the intersection of creativity and advocacy, offering inspiring insights on how we can all contribute to a more sustainable future.

Podcast Description: In this highlighted special episode of "The New Chemist's Podcast" the tables turn as Dr. Mike Zott, a talented postdoctoral researcher at the University of Pennsylvania, interviews his friend and colleague, David Ferguson. David, adjunct faculty and student at Howard University College of Pharmacy, steps into the guest seat to share personal stories, professional insights, and inspiring moments from his journey in pharmacy, academia, and beyond.Listeners will gain an insider's perspective on David's unique blend of teaching, podcasting, and research, alongside the secrets behind balancing multiple roles and thriving professionally. With engaging anecdotes, reflections on friendship and mentorship, and thoughtful advice for students and early-career professionals, this conversation provides meaningful inspiration and practical guidance.Join us for an authentic dialogue about navigating career paths, building professional communities, and pursuing passions with purpose.⁠The New Chemist Virtual internship⁠---Note: The views of the podcast reflect those of my guest(s) and I.Music citation: Music by ⁠Andrii Poradovskyi⁠ from ⁠Pixabay

Life's Chemistry Unleashed- Dialogues at the Edge of Discovery: Antibiotic Anthems and Rap Remixes --- In this episode, we produce with software assistance and AI programs, rap and anthems on antibiotics. --- Note: Some of the content produced involved the use of AI. Please note that these ideas do not constitute in any way medical advice, suggestions or recommendations, and we disclaim any loss in any way. --

In this episode, we feature insights from John Wells, the award-winning executive producer behind iconic television series like ER, The West Wing, and Shameless. With a career that has shaped television and explored themes of human endurance and leadership, John’s storytelling has left a lasting impact. We’ll also revisit conversations with other accomplished professionals throughout the series, emphasizing powerful ideas on resilience, innovation, and community-driven growth. If you find a value-driven initiative to support STEM education in your community, consider getting involved or volunteering to make a difference! -- Note: The views of this podcast represent those of my guest(s) and I. -- Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions. -- Some content produced involved the use of A.I.

-- In this highlighted episode, we highlight some of the concepts being discussed in cardiology integrated therapeutics pertaining to pharmacy students who are training! -- -- Note: The views of this podcast represent those of my guest(s) and I. -- Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions. -- Note: Music from public domain was used in background, and some the content produced involved the use of A.I. ---

Highlights from: The New Student Pharmacist's Podcast Experience- A Highlight of the Nobel Prize in Chemistry for 2024 with Other Pharmacy Conceptual Reviews -- Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions. Note: Some content produced involved the use of A.I..

Dr. Edward A. Botchwey is a Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. His research focuses on advancing regenerative medicine and immunoengineering through a convergence approach that integrates various disciplines and techniques for tissue repair and regeneration. Dr. Botchwey’s lab has made significant contributions in investigating S1P signaling in tissue repair and engineering in vivo gradients for microvascular remodeling, as well as developing regenerative immunotherapies using specialized pro-resolving lipid mediators (SPMs) and hydrogel-based delivery systems. This talk will mainly focus on targeting S1P signaling to promote tissue repair and regeneration, including the use of sphingosine kinase inhibitors (SK1i) to reduce local S1P levels and promote muscle fiber regeneration. Additionally, the development and application of ApoM-Fc-S1P, a novel S1P chaperone that enhances S1P receptor 1 signaling, will be discussed, highlighting its role in reducing fibrosis and improving muscle healing, particularly in aged animals. Advanced drug delivery systems such as nanofiber scaffolds and hydrogels, which provide localized and sustained release of therapeutic agents like FTY720, will also be introduced. These delivery systems enhance the efficacy of S1P-targeted therapies by ensuring higher drug concentration at the injury site, facilitating better integration and healing. The presentation will cover the use of ultrasound elastography as a noninvasive imaging technique to monitor tissue stiffness and fibrosis, providing valuable insights into the therapeutic efficacy of these approaches. Dr. Botchwey aims to develop innovative, equity-centered solutions to complex challenges in regenerative medicine, with potential applications in diverse fields such as regenerative immunotherapies, metabolic and hematologic disorders, and cell and tissue transplantation. Additionally, he is actively involved in promoting diversity and outreach through programs like SURE (Summer Undergraduate Research Experience) and ENGAGES (Engaging New Generations at Georgia Tech through Engineering and Science), which aim to provide underrepresented students with research opportunities and inspire the next generation of scientists and engineers. ---- Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions.

The New Student Pharmacist's Podcast Experience- The Ending of A Chapter in I.T. (Intergrated Therapeutics) --- Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions.   Some content produced involved the use of A.I. .

Highlights from: The New Student Pharmacist's Podcast Experience: Pharm 101: Unlocking the Power of Pharmacology -- Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions.   Some content produced involved the use of A.I. .  

The New Student Pharmacist Podcast Experience- Exploration of Cancer Biology and Research ---   Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions.   Some content produced involved the use of A.I. .

The New Student Pharmacist's Podcast Experience- Overview to the T of The Foundations of I.T. (Integrated Therapeutics) -- Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions.   Some content produced involved the use of A.I. .

The New Student Pharmacist's Podcast Experience- Biostatistics Overview: In this episode, we have a conversation, in which we talk briefly about biostatistics concepts. -- Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions. Some content produced involved the use of A.I. .

Please note: The views of this podcast represent those of my guest(s) and I. These are not for⁠ medical advice or consultation. Please see your local state and board-certified health professional. We disclaim any loss in any way. --- Highlights from TNSPPE- Interview with Dr. Sebastian Kahf,MD- Anesthesiology Resident, UCLA --- In this interview with one of my good friends, Dr. Kahf, MD, an anesthesiology resident at University of California, Los Angeles, we discuss his career journey thus far, recalling his first appearance on \"The New Chemist Podcast\" in 2021 to now appearing on \"The New Student Pharmacist Podcast Experience\". Definitely a good interview!-----Biography of Dr. Kahf, MD ( UCLA Anesthesiology Resident)---Sebastian Kahf is a first-year anesthesiology resident physician at UCLA. He went to Georgia Tech for undergrad and went to the Medical College of Georgia for his doctorate in medicine. In medical school, he conducted research in anesthesiology and presented his research in several state and national conferences as well as through publication in international-reach journals. By the end of medical school, he was selected for induction into the Alpha Omega Alpha (AOA) national medical honor society. He is now completing his first year as a physician out in Los Angeles, California. In his free time, he is an avid runner, skier, DJ, and has started to get into surfing during the summer months. He hopes to pursue a career in academic anesthesiology and serve as faculty to teach future generations of medical students and residents. ---⁠ ⁠Please note: The views of this podcast represent those of my guest(s) and I. These are not for⁠ medical advice or consultation. Please see your local state and board-certified health professional. We disclaim any loss in any way.